Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

Introduction: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease with high symptom burden, of unknown etiology, with no established treatment. We observed patients with long-standing ME/CFS who got cancer, and who reported improvement of ME/CFS symptoms after chemotherapy inclu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Autores principales: Rekeland, Ingrid G., Fosså, Alexander, Lande, Asgeir, Ktoridou-Valen, Irini, Sørland, Kari, Holsen, Mari, Tronstad, Karl J., Risa, Kristin, Alme, Kine, Viken, Marte K., Lie, Benedicte A., Dahl, Olav, Mella, Olav, Fluge, Øystein
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7201056/
https://ncbi.nlm.nih.gov/pubmed/32411717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00162
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares